![Russell Skibsted](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Russell Skibsted
Director of Finance/CFO at
PROCESSA PHARMACEUTICALS, INC.
Net worth: 42 724 $ as of 30/05/2026
Profile
Russell L.
Skibsted is currently Chief Financial Officer at Processa Pharmaceuticals, Inc. since 2024.
Former roles include Chief Financial Officer & Senior Vice President at Alimera Sciences, Inc. (2023–2024), Chief Financial Officer at Asterias Biotherapeutics, Inc. (2016), Chief Financial & Accounting Officer at Insight Molecular Diagnostics, Inc. (2015–2017), Chief Financial & Accounting Officer at Lineage Cell Therapeutics, Inc. (2015–2019), Chief Financial Officer at Proove Biosciences, Inc. (2013–2015), Chief Financial Officer, Secretary, CAO & SVP at Aeolus Pharmaceuticals, Inc. (2013), Chief Financial Officer & Managing Director at RSL Venture Partners LP (2013–2014), Chief Financial Officer & Executive Vice President at Pharmagen, Inc. (2014), Chief Financial Officer at Talon Therapeutics, Inc. (2004–2006), Chief Financial Officer & Partner at Asset Management Co. (2000–2004), Chief Business Officer & Senior Vice President at Spectrum Pharmaceuticals, Inc. (2006–2009), Executive VP, Chief Financial & Business Officer at Rockwell Medical, Inc., Director-Corporate Development at Pinkerton, Inc., Vice President at GE Capital Services, and Chief Financial Officer at AgeX Therapeutics, Inc. Education includes undergraduate studies at Claremont McKenna College and an MBA from Stanford Graduate School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/06/2026 | 16,689 ( 0.61% ) | 42 724 $ | 30/05/2026 |
Russell Skibsted active positions
| Companies | Position | Start |
|---|---|---|
| PROCESSA PHARMACEUTICALS, INC. | Director of Finance/CFO | 15/07/2024 |
Former positions of Russell Skibsted
| Companies | Position | End |
|---|---|---|
| ALIMERA SCIENCES, INC. | Director of Finance/CFO | 01/01/2024 |
| AGEX THERAPEUTICS, INC. | Director of Finance/CFO | 14/05/2020 |
| LINEAGE CELL THERAPEUTICS, INC. | Director of Finance/CFO | 06/01/2019 |
| ASTERIAS BIOTHERAPEUTICS INC | Director of Finance/CFO | 16/11/2016 |
Proove Biosciences, Inc.
 Proove Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates pain medicine laboratory that provides proprietary genetic testing services to help physicians | Director of Finance/CFO | 31/10/2015 |
Training of Russell Skibsted
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
54
1st degree connections
18
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
Lineage Cell Therapeutics, Inc.
 Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
Spectrum Pharmaceuticals, Inc.
 Spectrum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel and targeted oncology & hematology drug products | Health Technology |
Rockwell Medical, Inc.
 Rockwell Medical, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes hemodialysis concentrate products and dialysis kits | Health Technology |
Alimera Sciences, Inc.
 Alimera Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops, manufactures and commercializes therapeutics for ophthalmology, rheumatology, nephrology, neurology & pulmonology problems | Health Technology |
Pharmagen, Inc.
 Pharmagen, Inc. Medical DistributorsDistribution Services Operates as a distributor of drugs, compounding and admix pharmacy | Distribution Services |
Asterias Biotherapeutics, Inc.
 Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes regenerative medicine for neurology and oncology applications | Health Technology |
GE Capital Services
 GE Capital Services Aerospace & DefenseElectronic Technology Diversified manufacturer of high-tech products | Electronic Technology |
Aeolus Pharmaceuticals, Inc.
 Aeolus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Claremont McKenna College
 Claremont McKenna College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Asset Management Co.
 Asset Management Co. Investment ManagersFinance Alternative investment manager | Finance |
Pinkerton, Inc. | |
RSL Venture Partners LP
 RSL Venture Partners LP Financial ConglomeratesFinance Provides investment services | Finance |
OncoCyte Corp.
 OncoCyte Corp. BiotechnologyHealth Technology Focuses on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer | Health Technology |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Proove Biosciences, Inc.
Proove Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates pain medicine laboratory that provides proprietary genetic testing services to help physicians | Commercial Services |
AgeX Therapeutics, Inc.
 AgeX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics | Health Technology |
Processa Pharmaceuticals, Inc.
 Processa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products | Health Technology |
- Stock Market
- Insiders
- Russell Skibsted
